Walking the Line Between Marketing and Malfeasance

Published date07 October 2019
Subject MatterDOJ,Bribery,Anti-Kickback Statute,RICO,Qui Tam,Criminal Prosecution,Physicians,Prescription Drugs,Racketeering,DEA,Criminal Investigations,False Claims Act (FCA),Pharmaceutical Industry,Opioid
AuthorTaylor Mayes,Katelyn Marshall
Law FirmButler Snow LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT